Clinical trial
Fixed Low-dose Simethicone Combined With Macrogol 4000 (PEG) Reduces Colon Bubble Formation in Colonoscopy: Phase 4 Prospective Multicenter Real Life Study
NCT06319924 is registered in ClinicalTrials.gov with Hospital St. Joseph, Marseille, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fixed Low-dose Simethicone Combined With Macrogol 4000 (PEG) Reduces Colon Bubble Formation in Colonoscopy: Phase 4 Prospective Multicenter Real Life Study
- Lead sponsor
- Hospital St. Joseph, Marseille, France
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 1, 2020
- Completion date
- September 15, 2022
- Enrollment
- 601 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
bowel preparation solution, colonoscopy, colorectal cancer